Sweden's Biosergen Seeks Delisting from Nasdaq First North Growth Market

MT Newswires · 3d ago
01:18 AM EDT, 09/16/2026 (MT Newswires) -- Biosergen (BIOSGN.ST) decided to apply to delist its shares from Nasdaq First North Growth Market, according to a Tuesday release. The application follows the biotechnology company's planned merger with life science investor Flerie (FLERIE.ST) and is conditional on the Swedish Companies Registration Office's approval for its execution and completion. Biosergen expects the last day of trading to be Oct. 21.